AntiCan Cancer Research Results

AntiCan, Anticancer Effect: Click to Expand ⟱
Source:
Type: general indicator
Anticancer Effect


BC, Breast Cancer: Click to Expand ⟱
Breast Cancer

Scientific Papers found: Click to Expand⟱
4431- AgNPs,  doxoR,    Oxidative Stress-Induced Silver Nano-Carriers for Chemotherapy
- in-vitro, BC, 4T1 - in-vivo, BC, 4T1 - in-vitro, Nor, 3T3
AntiCan↑, ROS↑, TumVol↓, EPR↑, selectivity↑, ChemoSen↑,
4548- AgNPs,  Chit,    Synergistic combination of antioxidants, silver nanoparticles and chitosan in a nanoparticle based formulation: Characterization and cytotoxic effect on MCF-7 breast cancer cell lines
- in-vitro, BC, MCF7
AntiCan↑, EPR↑, pH↝,
1447- Bos,    Boswellia carterii n-hexane extract suppresses breast cancer growth via induction of ferroptosis by downregulated GPX4 and upregulated transferrin
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7 - in-vivo, BC, 4T1 - in-vitro, Nor, MCF10
tumCV↓, AntiCan↑, *toxicity↓, Ferroptosis↑, i-Iron↑, GPx4↓, ROS↑, lipid-P↑, Tf↑, TumCG↓,
6305- Cro,    Bridging Preclinical and Clinical Evidence on Crocin in Breast Cancer
- Review, BC, NA
AntiCan↑, Apoptosis↑, TumCCA↑, angioG↓, TumCG↓, ChemoSen↑,
7411- CS,    Long Term Exposure to Polyphenols of Artichoke (Cynara scolymus L.) Exerts Induction of Senescence Driven Growth Arrest in the MDA-MB231 Human Breast Cancer Cell Line
- in-vitro, BC, MDA-MB-231 - in-vitro, CRC, HCT116
AntiCan↑, chemoPv↑, Apoptosis↑, TumCI↓, Casp↑, p16↑, P21↑, TumCCA↑, ROS↓, eff↓, TumCD↑, TumCG↓, cellSen↑, *ROS↓,
1865- DCA,    Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo
- in-vivo, BC, NA - in-vitro, BC, MCF7 - in-vitro, BC, T47D
TumCG↓, TumCP↓, AntiCan↑,
6665- DFE,    Cytotoxic Effect of Phoenix dactylifera (Iraqi Date) Leaves and Fruits Extracts against Breast Cancers Cell Lines
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, CAL51 - in-vitro, BC, MCF7
TumCD↑, eff↓, selectivity↑, AntiCan↑, TumCP↓, MMP↓, cl‑Casp3↑, cl‑PARP↑,
6587- EU,    Eurycoma longifolia, A Potential Phytomedicine for the Treatment of Cancer: Evidence of p53-mediated Apoptosis in Cancerous Cells
- in-vitro, Lung, A549 - in-vitro, BC, MCF7
AntiCan↑, Apoptosis↑, P53↑, BAX↑, Bcl-2↓, PHB↓, ANXA1↓, hnRNPA1↓,
6972- Form,  PacT,    Formononetin ameliorates the drug resistance of Taxol resistant triple negative breast cancer by inhibiting autophagy
- in-vivo, BC, MDA-MB-231
AntiCan↑, miR-199↓, ChemoSen↑, TumVol↓, Dose↝, TumCG↓, TumCCA↑, Apoptosis↑, TumAuto↓, eff↓,
7356- HibSad,    Hibiscus flower extract selectively induces apoptosis in breast cancer cells and positively interacts with common chemotherapeutics
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231
AntiCan↑, Apoptosis↑, selectivity↑, ChemoSen↑, ROS↑, MMP↓, eff↑,
7472- Hops,    Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids
- in-vitro, BC, SkBr3
CYP19↓, TumCP↓, Apoptosis↑, AntiCan↑,
4633- HT,    Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells
- in-vitro, BC, NA
AntiCan↑, CSCs↓, antiOx↑, NQO1↑, TumCCA↑, ER Stress↑, Apoptosis↑, UPR↑,
7385- IBC,    Fighting cancer by triggering non-canonical mitochondrial permeability transition-driven necrosis through reactive oxygen species induction
- vitro+vivo, Lung, A549 - in-vitro, BC, 4T1
Apoptosis↑, necrosis↑, ROS↑, mtDam↑, Ca+2↑, MPT↑, MMP↓, AntiCan↑, *AntiBio↑, *Inflam↓, *antiOx↓, *neuroP↑, p‑Akt↓, DHODH↓, Diff↑, MAPK↑,
4786- Lyco,    Anti-proliferative and apoptosis-inducing activity of lycopene against three subtypes of human breast cancer cell lines
- in-vitro, BC, MDA-MB-468 - in-vitro, BC, MCF7 - in-vitro, BC, SkBr3
TumCP↓, TumCCA↑, cl‑PARP↑, ERK↑, cycD1/CCND1↓, P21↓, p‑Akt↓, mTOR↓, BAX↑, AntiCan↑, Risk↓,
526- MF,    Inhibition of Cancer Cell Growth by Exposure to a Specific Time-Varying Electromagnetic Field Involves T-Type Calcium Channels
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7 - in-vitro, Pca, HeLa - vitro+vivo, Melanoma, B16-BL6 - in-vitro, Nor, HEK293
TumCG↓, Ca+2↑, selectivity↑, *Ca+2∅, ROS↑, HSP70/HSPA5↑, AntiCan↑,
1672- PBG,    The Potential Use of Propolis as an Adjunctive Therapy in Breast Cancers
- Review, BC, NA
ChemoSen↓, RadioS↑, Inflam↓, AntiCan↑, Dose∅, mtDam↑, Apoptosis?, OCR↓, ATP↓, ROS↑, ROS↑, LDH↓, TP53↓, Casp3↓, BAX↓, P21↓, ROS↑, eNOS↑, iNOS↑, eff↑, hTERT/TERT↓, cycD1/CCND1↓, eff↑, eff↑, eff↑, eff↑, STAT3↓, TIMP1↓, IL4↓, IL10↓, OS↑, Dose∅, ER Stress↑, ROS↑, NF-kB↓, p65↓, MMP↓, TumAuto↑, LC3II↑, p62↓, TLR4↓, mtDam↑, LDH↓, ROS↑, Glycolysis↓, HK2↓, PFK↓, PKM2↓, LDH↓, IL10↓, HDAC8↓, eff↑, eff↑, P21↑,
7381- RS,    In-vitro anticancer activity of Rauvolfia tetraphylla extract on mcf-7 breast cancer cell lines
- in-vitro, BC, MCF7
AntiCan↑, Apoptosis↑, DNAdam↑, Bcl-2↓, TGF-β↓, Dose↝,
5004- Sal,    Targeting Telomerase Enhances Cytotoxicity of Salinomycin in Cancer Cells
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231
eff↑, AntiCan↑, CSCs↑, Wnt↓, β-catenin/ZEB1↓, Diff↑, ROS↑, toxicity↝, selectivity↝, eff↑,
4501- SeNPs,    Mechanisms of the Cytotoxic Effect of Selenium Nanoparticles in Different Human Cancer Cell Lines
- in-vitro, GBM, A172 - in-vitro, Colon, Caco-2 - in-vitro, Pca, DU145 - in-vitro, BC, MCF7 - in-vitro, Nor, L929
*BioAv↑, selectivity↑, AntiCan↑, Apoptosis↑, CHOP/DDIT3↑, GADD34↑, BIM↑, PUMA↑, Ca+2↝,
4470- SeNPs,  Chit,    Synthesis and cytotoxic activities of selenium nanoparticles incorporated nano-chitosan
- in-vitro, CRC, HCT116 - in-vitro, Liver, HepG2 - in-vitro, BC, MCF7
Dose↝, AntiCan↑, eff↑,
4473- SeNPs,    Anti-cancerous effect and biological evaluation of green synthesized Selenium nanoparticles on MCF-7 breast cancer and HUVEC cell lines
- in-vitro, BC, MCF7 - in-vitro, Nor, HUVECs
AntiCan↑, selectivity↓, *Bacteria↓, *antiOx↑, *toxicity↓, ROS↑, tumCV↓,
3305- SIL,    Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7 - in-vivo, NA, NA
TumCP↓, tumCV↓, BAX↑, cl‑PARP↑, Casp9↑, p‑JNK↑, Bcl-2↓, p‑p38↓, p‑ERK↓, *toxicity∅, Dose↝, *hepatoP↑, Inflam↓, AntiCan↑,

Showing Research Papers: 1 to 22 of 22

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 22

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0)

DHODH↓, 1,   miR-199↓, 1,  

Redox & Oxidative Stress(tgid=1)

antiOx↑, 1,   Ferroptosis↑, 1,   GPx4↓, 1,   i-Iron↑, 1,   lipid-P↑, 1,   NQO1↑, 1,   ROS↓, 1,   ROS↑, 12,  

Metal & Cofactor Biology(tgid=2)

Tf↑, 1,  

Mitochondria & Bioenergetics(tgid=3)

ATP↓, 1,   MMP↓, 4,   MPT↑, 1,   mtDam↑, 3,   OCR↓, 1,   PHB↓, 1,  

Core Metabolism/Glycolysis(tgid=4)

Glycolysis↓, 1,   HK2↓, 1,   LDH↓, 3,   PFK↓, 1,   PKM2↓, 1,  

Cell Death(tgid=5)

p‑Akt↓, 2,   Apoptosis?, 1,   Apoptosis↑, 10,   BAX↓, 1,   BAX↑, 3,   Bcl-2↓, 3,   BIM↑, 1,   Casp↑, 1,   Casp3↓, 1,   cl‑Casp3↑, 1,   Casp9↑, 1,   Ferroptosis↑, 1,   GADD34↑, 1,   hTERT/TERT↓, 1,   iNOS↑, 1,   p‑JNK↑, 1,   MAPK↑, 1,   necrosis↑, 1,   p‑p38↓, 1,   PUMA↑, 1,   TumCD↑, 2,  

Transcription & Epigenetics(tgid=7)

tumCV↓, 3,  

Protein Folding & ER Stress(tgid=8)

CHOP/DDIT3↑, 1,   ER Stress↑, 2,   HSP70/HSPA5↑, 1,   UPR↑, 1,  

Autophagy & Lysosomes(tgid=9)

LC3II↑, 1,   p62↓, 1,   TumAuto↓, 1,   TumAuto↑, 1,  

DNA Damage & Repair(tgid=10)

DNAdam↑, 1,   p16↑, 1,   P53↑, 1,   cl‑PARP↑, 3,   TP53↓, 1,  

Cell Cycle & Senescence(tgid=11)

cycD1/CCND1↓, 2,   P21↓, 2,   P21↑, 2,   TumCCA↑, 5,  

Proliferation, Differentiation & Cell State(tgid=12)

CSCs↓, 1,   CSCs↑, 1,   Diff↑, 2,   ERK↑, 1,   p‑ERK↓, 1,   HDAC8↓, 1,   mTOR↓, 1,   STAT3↓, 1,   TumCG↓, 6,   Wnt↓, 1,  

Migration(tgid=13)

Ca+2↑, 2,   Ca+2↝, 1,   hnRNPA1↓, 1,   TGF-β↓, 1,   TIMP1↓, 1,   TumCI↓, 1,   TumCP↓, 5,   β-catenin/ZEB1↓, 1,  

Angiogenesis & Vasculature(tgid=14)

angioG↓, 1,   eNOS↑, 1,   EPR↑, 2,  

Immune & Inflammatory Signaling(tgid=16)

ANXA1↓, 1,   cellSen↑, 1,   IL10↓, 2,   IL4↓, 1,   Inflam↓, 2,   NF-kB↓, 1,   p65↓, 1,   TLR4↓, 1,  

Cellular Microenvironment(tgid=17)

pH↝, 1,  

Hormonal & Nuclear Receptors(tgid=20)

CYP19↓, 1,  

Drug Metabolism & Resistance(tgid=21)

ChemoSen↓, 1,   ChemoSen↑, 4,   Dose↝, 4,   Dose∅, 2,   eff↓, 3,   eff↑, 11,   RadioS↑, 1,   selectivity↓, 1,   selectivity↑, 5,   selectivity↝, 1,  

Clinical Biomarkers(tgid=22)

hTERT/TERT↓, 1,   LDH↓, 3,   TP53↓, 1,  

Functional Outcomes(tgid=23)

AntiCan↑, 22,   chemoPv↑, 1,   OS↑, 1,   Risk↓, 1,   toxicity↝, 1,   TumVol↓, 2,  
Total Targets: 111

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0)

AntiBio↑, 1,  

Redox & Oxidative Stress(tgid=1)

antiOx↓, 1,   antiOx↑, 1,   ROS↓, 1,  

Migration(tgid=13)

Ca+2∅, 1,  

Immune & Inflammatory Signaling(tgid=16)

Inflam↓, 1,  

Drug Metabolism & Resistance(tgid=21)

BioAv↑, 1,  

Functional Outcomes(tgid=23)

hepatoP↑, 1,   neuroP↑, 1,   toxicity↓, 2,   toxicity∅, 1,  

Infection & Microbiome(tgid=24)

Bacteria↓, 1,  
Total Targets: 12

Scientific Paper Hit Count for: AntiCan, Anticancer Effect
3 Selenium NanoParticles
2 Silver-NanoParticles
2 chitosan
1 doxorubicin
1 Boswellia (frankincense)
1 Crocetin
1 Cynara scolymus/Globe Artichoke/Artichoke Extract
1 Dichloroacetate
1 Date Fruit Extract
1 Eurycomanone
1 Formononetin
1 Paclitaxel/Taxol
1 Hibiscus sabdariffa
1 Hops (Humulus lupulus)
1 HydroxyTyrosol
1 Isobavachalcone
1 Lycopene
1 Magnetic Fields
1 Propolis -bee glue
1 Rauwolfia serpentina/Indian Snakeroot
1 salinomycin
1 Silymarin (Milk Thistle) silibinin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:4  Cells:%  prod#:%  Target#:813  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page